CTTC staff members work diligently to manage all disclosures and requests in a timely manner. Below is a sampling of the activity that has taken place in our office over the past few weeks:
Held preliminary discussions with a medical device company regarding the licensing and collaboration of Vanderbilt’s Sterile blood culture collection kit technology developed by Dr. Wesley H. Self from Department of Emergency Medicine.
Hosted attorneys from Michael Best & Friedrich, LLC, who led a session on current trends involving non-patenting entities (NPEs or "patent trolls").
Held a call with an early-stage venture capital firm to market the drug development and diagnostic assay capabilities at Vanderbilt as well as the BioVU genetic database.
Presented a webinar about the therapeutic uses of phospholipase D inhibitor compounds for cancer and infectious disease to a pharmaceutical company. These compounds are under development by H. Alex Brown and Craig W. Lindsley from the Department of Pharmacology and the Vanderbilt Center for Neuroscience Drug Discovery, respectively.
Hosted Rahn Huber from the Walker library for a session on efficient search strategies using their databases.
a webinar to a national audience of technology transfer professionals regarding MTAShare
, Vanderbilt's automated system for managing the transfer of research materials.
in VUMC's Reporter
for record number of licensing deals in FY14.